These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 7702575)

  • 1. Mechanism of anti-proliferation caused by YC-1, an indazole derivative, in cultured rat A10 vascular smooth-muscle cells.
    Yu SM; Cheng ZJ; Guh JH; Lee FY; Kuo SC
    Biochem J; 1995 Mar; 306 ( Pt 3)(Pt 3):787-92. PubMed ID: 7702575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiproliferative effects of A02011-1, an adenylyl cyclase activator, in cultured vascular smooth muscle cells of rat.
    Yu SM; Cheng ZJ; Kuo SC
    Br J Pharmacol; 1995 Mar; 114(6):1227-35. PubMed ID: 7620713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. YC-1-mediated vascular protection through inhibition of smooth muscle cell proliferation and platelet function.
    Tulis DA; Bohl Masters KS; Lipke EA; Schiesser RL; Evans AJ; Peyton KJ; Durante W; West JL; Schafer AI
    Biochem Biophys Res Commun; 2002 Mar; 291(4):1014-21. PubMed ID: 11866467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of soluble guanylyl cyclase by YC-1 in aortic smooth muscle but not in ventricular myocardium from rat.
    Wegener JW; Gath I; Förstermann U; Nawrath H
    Br J Pharmacol; 1997 Dec; 122(7):1523-9. PubMed ID: 9421305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. YC-1 inhibited human platelet aggregation through NO-independent activation of soluble guanylate cyclase.
    Wu CC; Ko FN; Kuo SC; Lee FY; Teng CM
    Br J Pharmacol; 1995 Oct; 116(3):1973-8. PubMed ID: 8640334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. YC-1 inhibits proliferation of human vascular endothelial cells through a cyclic GMP-independent pathway.
    Hsu HK; Juan SH; Ho PY; Liang YC; Lin CH; Teng CM; Lee WS
    Biochem Pharmacol; 2003 Jul; 66(2):263-71. PubMed ID: 12826268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of YC-1, an NO-independent, superoxide-sensitive stimulator of soluble guanylyl cyclase, on smooth muscle responsiveness to nitrovasodilators.
    Mülsch A; Bauersachs J; Schäfer A; Stasch JP; Kast R; Busse R
    Br J Pharmacol; 1997 Feb; 120(4):681-9. PubMed ID: 9051308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. YC-1-inhibited proliferation of rat mesangial cells through suppression of cyclin D1-independent of cGMP pathway and partially reversed by p38 MAPK inhibitor.
    Chiang WC; Teng CM; Lin SL; Chen YM; Tsai TJ; Hsieh BS
    Eur J Pharmacol; 2005 Jul; 517(1-2):1-10. PubMed ID: 15950964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. YC-1 stimulates the expression of gaseous monoxide-generating enzymes in vascular smooth muscle cells.
    Liu XM; Peyton KJ; Mendelev NN; Wang H; Tulis DA; Durante W
    Mol Pharmacol; 2009 Jan; 75(1):208-17. PubMed ID: 18923065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the soluble guanylyl cyclase activator, YC-1, on vascular tone, cyclic GMP levels and phosphodiesterase activity.
    Galle J; Zabel U; Hübner U; Hatzelmann A; Wagner B; Wanner C; Schmidt HH
    Br J Pharmacol; 1999 May; 127(1):195-203. PubMed ID: 10369473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of isoliquiritigenin and YC-1 in rat aortic smooth muscle.
    Wegener JW; Nawrath H
    Eur J Pharmacol; 1997 Mar; 323(1):89-91. PubMed ID: 9105881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble guanylyl cyclase activator YC-1 inhibits human neutrophil functions through a cGMP-independent but cAMP-dependent pathway.
    Hwang TL; Hung HW; Kao SH; Teng CM; Wu CC; Cheng SJ
    Mol Pharmacol; 2003 Dec; 64(6):1419-27. PubMed ID: 14645672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. YC-1, a novel activator of platelet guanylate cyclase.
    Ko FN; Wu CC; Kuo SC; Lee FY; Teng CM
    Blood; 1994 Dec; 84(12):4226-33. PubMed ID: 7527671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Release of nitric oxide from endothelial cells stimulated by YC-1, an activator of soluble guanylyl cyclase.
    Wohlfart P; Malinski T; Ruetten H; Schindler U; Linz W; Schoenafinger K; Strobel H; Wiemer G
    Br J Pharmacol; 1999 Nov; 128(6):1316-22. PubMed ID: 10578147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiproliferative effects of PCA-4230, a new antithrombotic drug, in vascular smooth muscle cells.
    del Rio M; Sunkel C; Larcher F; Ortega MP
    Br J Pharmacol; 1997 Apr; 120(7):1360-6. PubMed ID: 9105713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. YC-1, a nitric oxide-independent activator of soluble guanylate cyclase, inhibits the spontaneous contractions of isolated pregnant rat myometrium.
    Cetin A; Kaya T; Demirkoprulu N; Karadas B; Duran B; Cetin M
    J Pharmacol Sci; 2004 Jan; 94(1):19-24. PubMed ID: 14745113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interference of neutrophil-platelet interaction by YC-1: a cGMP-dependent manner on heterotypic cell-cell interaction.
    Liao CH; Cheng JT; Teng CM
    Eur J Pharmacol; 2005 Sep; 519(1-2):158-67. PubMed ID: 16112105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. YC-1 potentiates nitric oxide- and carbon monoxide-induced cyclic GMP effects in human platelets.
    Friebe A; Müllershausen F; Smolenski A; Walter U; Schultz G; Koesling D
    Mol Pharmacol; 1998 Dec; 54(6):962-7. PubMed ID: 9855623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. L-Citrulline, the by-product of nitric oxide synthesis, decreases vascular smooth muscle cell proliferation.
    Ruiz E; Del Rio M; Somoza B; Ganado P; Sanz M; Tejerina T
    J Pharmacol Exp Ther; 1999 Jul; 290(1):310-3. PubMed ID: 10381792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pentoxifylline inhibits PDGF-induced proliferation of and TGF-beta-stimulated collagen synthesis by vascular smooth muscle cells.
    Chen YM; Wu KD; Tsai TJ; Hsieh BS
    J Mol Cell Cardiol; 1999 Apr; 31(4):773-83. PubMed ID: 10329205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.